131 – 140 of 397
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Editorial: Long in the shade, glucagon re-occupies centre court
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Effects of increasing doses of glucagon-like peptide-1 on insulin-releasing phases during intravenous glucose administration in mice
2011) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 300(5). p.1126-1133(
- Contribution to journal › Article
-
Mark
The dynamic incretin adaptation and type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice.
(
- Contribution to journal › Article
-
Mark
Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
GLP-1 for type 2 diabetes
(
- Contribution to journal › Scientific review
-
Mark
Positive correlation between tumor necrosis factor (TNF)-alpha and cardiorespiratory fitness after six-months of regular aerobic exercise in Peruvian Amerindian women
(
- Contribution to journal › Article
-
Mark
Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.
(
- Contribution to journal › Scientific review
-
Mark
Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
(
- Contribution to journal › Article
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
(
- Contribution to journal › Article